Soria JC - Search Results

1

Vascular disrupting therapy-induced mobilization of circulating endothelial progenitor cells.

Farace F, Massard C, Borghi E, Bidart JM, Soria JC. Farace F, et al. Among authors: soria jc. Ann Oncol. 2007 Aug;18(8):1421-2. doi: 10.1093/annonc/mdm367. Ann Oncol. 2007. PMID: 17693656 Free article. Clinical Trial. No abstract available.

2

Tumour stem cell-targeted treatment: elimination or differentiation.

Massard C, Deutsch E, Soria JC. Massard C, et al. Among authors: soria jc. Ann Oncol. 2006 Nov;17(11):1620-4. doi: 10.1093/annonc/mdl074. Epub 2006 May 3. Ann Oncol. 2006. PMID: 16600978 Free article. Review.

3

Treatment outcome and survival in participants of phase I oncology trials carried out from 2003 to 2006 at Institut Gustave Roussy.

Italiano A, Massard C, Bahleda R, Vataire AL, Deutsch E, Magné N, Pignon JP, Vassal G, Armand JP, Soria JC. Italiano A, et al. Among authors: soria jc. Ann Oncol. 2008 Apr;19(4):787-92. doi: 10.1093/annonc/mdm548. Epub 2007 Nov 27. Ann Oncol. 2008. PMID: 18042834 Free article. Review.

4

[Eruptive nevi associated with sorafenib treatment].

Bennani-Lahlou M, Mateus C, Escudier B, Massard C, Soria JC, Spatz A, Robert C. Bennani-Lahlou M, et al. Among authors: soria jc. Ann Dermatol Venereol. 2008 Oct;135(10):672-4. doi: 10.1016/j.annder.2008.04.016. Epub 2008 Jul 30. Ann Dermatol Venereol. 2008. PMID: 18929917 French.

5

[Everolimus (RAD001) and solid tumours: a 2008 summary].

Lévy A, Sauvin LA, Massard C, Soria JC. Lévy A, et al. Among authors: soria jc. Bull Cancer. 2008 Dec;95(12):1205-11. doi: 10.1684/bdc.2008.0767. Bull Cancer. 2008. PMID: 19091655 Review. French.

6

Cutaneous side-effects in patients on long-term treatment with epidermal growth factor receptor inhibitors.

Osio A, Mateus C, Soria JC, Massard C, Malka D, Boige V, Besse B, Robert C. Osio A, et al. Among authors: soria jc. Br J Dermatol. 2009 Sep;161(3):515-21. doi: 10.1111/j.1365-2133.2009.09214.x. Epub 2009 Apr 10. Br J Dermatol. 2009. PMID: 19466958

7

[Molecular targeted therapies in small-cell lung cancer].

Levy A, Malouf GG, Besse B, Massard C, Soria JC. Levy A, et al. Among authors: soria jc. Bull Cancer. 2010 May;97(5):535-45. doi: 10.1684/bdc.2010.1035. Bull Cancer. 2010. PMID: 20093224 Review. French.

8

FGFR inhibitor induced peripheral neuropathy in patients with advanced RCC.

Loriot Y, Massard C, Angevin E, Lambotte O, Escudier B, Soria JC. Loriot Y, et al. Among authors: soria jc. Ann Oncol. 2010 Jul;21(7):1559-1560. doi: 10.1093/annonc/mdq237. Epub 2010 May 5. Ann Oncol. 2010. PMID: 20444848 Free article. No abstract available.

9

Total recall of radiotherapy with mTOR inhibitors: a novel and potentially frequent side-effect?

Bourgier C, Massard C, Moldovan C, Soria JC, Deutsch E. Bourgier C, et al. Among authors: soria jc. Ann Oncol. 2011 Feb;22(2):485-6. doi: 10.1093/annonc/mdq741. Ann Oncol. 2011. PMID: 21278224 Free article. No abstract available.

10

Phase I safety, pharmacokinetic and pharmacodynamic trial of BMS-599626 (AC480), an oral pan-HER receptor tyrosine kinase inhibitor, in patients with advanced solid tumors.

Soria JC, Cortes J, Massard C, Armand JP, De Andreis D, Ropert S, Lopez E, Catteau A, James J, Marier JF, Beliveau M, Martell RE, Baselga J. Soria JC, et al. Ann Oncol. 2012 Feb;23(2):463-71. doi: 10.1093/annonc/mdr137. Epub 2011 May 16. Ann Oncol. 2012. PMID: 21576284 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

736 results

Search Page

Filters